Author

E. Hoque Apu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Rahman Tanu· 1 shared A. Tundo· 1 shared A. V. Makela· 1 shared C. H. Contag· 1 shared C. V. Maduka· 1 shared E. Ural· 1 shared F. Mobin· 1 shared J. H. Elisseeff· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Rahman Tanu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Regulating the proinflammatory response to implanted composite biomaterials comprising polylactide and hydroxyapatite by targeting immunometabolism

C. V. Maduka, A. V. Makela, E. Ural, K. B. Stivers, M. M. Kuhnert, A. Tundo, M. Alhaj, E. Hoque Apu, N. Ashammakhi, K. D. Hankenson, R. Narayan, J. H. Elisseeff, C. H. Contag

This study modulates the inflammatory response to PLA-HA biomaterials by targeting immunometabolism, reducing proinflammatory cells and increasing pro-regenerative ones.

bioRxiv · Oct 21, 2023Bioengineering

CDK4 as a phytochemical based anticancer drug target

R. K. Chando, N. Hussain, M. Islam Rana, S. Sayed, S. Alam, T. Ahmed Fakir, S. Sharma, A. Rahman Tanu, F. Mobin, E. Hoque Apu, M. K. Hasan, M. A. Sayed, M. A. Ashraf

This study identifies mangiferin, a compound from mango trees, as a potential anticancer drug targeting CDK4, which is linked to cancer survival rates and expression patterns in GBM, LGG, and SARC.

bioRxiv · Nov 29, 2019 · PreprintCancer Biology